VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,717 | -34.4% | 7,342 | 0.0% | 0.00% | – |
| Q2 2023 | $48,384 | -2.9% | 7,342 | 0.0% | 0.00% | – |
| Q1 2023 | $49,852 | -8.1% | 7,342 | 0.0% | 0.00% | – |
| Q4 2022 | $54,257 | -25.7% | 7,342 | 0.0% | 0.00% | – |
| Q3 2022 | $73,000 | -8.8% | 7,342 | 0.0% | 0.00% | – |
| Q2 2022 | $80,000 | -3.6% | 7,342 | 0.0% | 0.00% | – |
| Q1 2022 | $83,000 | -27.8% | 7,342 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $115,000 | +17.3% | 7,342 | +28.0% | 0.00% | 0.0% |
| Q3 2021 | $98,000 | -22.2% | 5,736 | -40.1% | 0.00% | 0.0% |
| Q4 2020 | $126,000 | +37.0% | 9,575 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $92,000 | -16.4% | 9,575 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $110,000 | +175.0% | 9,575 | +147.0% | 0.00% | – |
| Q1 2020 | $40,000 | -37.5% | 3,876 | 0.0% | 0.00% | – |
| Q4 2019 | $64,000 | +25.5% | 3,876 | 0.0% | 0.00% | – |
| Q3 2019 | $51,000 | -7.3% | 3,876 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -22.5% | 3,876 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $71,000 | -29.7% | 3,876 | +0.5% | 0.00% | 0.0% |
| Q4 2018 | $101,000 | +14.8% | 3,855 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $88,000 | +33.3% | 3,855 | +11.2% | 0.00% | 0.0% |
| Q2 2018 | $66,000 | +153.8% | 3,467 | +127.0% | 0.00% | – |
| Q1 2018 | $26,000 | +13.0% | 1,527 | 0.0% | 0.00% | – |
| Q4 2017 | $23,000 | -14.8% | 1,527 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +8.0% | 1,527 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | +19.0% | 1,527 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | -12.5% | 1,527 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -4.0% | 1,527 | 0.0% | 0.00% | – |
| Q3 2016 | $25,000 | +108.3% | 1,527 | +47.7% | 0.00% | – |
| Q2 2016 | $12,000 | +33.3% | 1,034 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -10.0% | 1,034 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -16.7% | 1,034 | 0.0% | 0.00% | – |
| Q3 2015 | $12,000 | – | 1,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |